Company: MDCXW
Filing Date: 2025-09-18
Form Type: 253G2
Source: 0001062993-25-015705
Chunk: 3

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-18
Form: 253G2
Chunk 3
---
 the Debenture in monthly installments of $650,000 plus accrued and unpaid interest, in cash, as of such payment date starting on the 45-day anniversary of the issuance date of the Debenture. Any principal and interest outstanding as of the Maturity Date will be due and payable on the Maturity Date.

The Debenture provides the Company with an optional redemption right pursuant to which the Company, at any time, may redeem in cash, in whole or in part, all amounts outstanding under the Debenture prior to the Maturity Date. The redemption amount shall be equal to the outstanding principal balance being redeemed by the Company, plus all accrued and unpaid interest in respect of such redeemed principal amount as of such redemption date.

The foregoing descriptions of the Purchase Agreement, Guaranty and Debenture do not purport to be complete and are qualified in their entirety by reference to the full text of such documents, which are filed herewith as Exhibits 10.1, 10.2 and 4.1, respectively, and are incorporated herein by reference.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein in its entirety.

Item 9.01. Financial Statements and Exhibits. (d) Exhibits.

| Exhibit 
 No.     
 4.1*    
 10.1*

#  |     | Description                                                                                                                                                                                                                                       
 Debenture dated as of September 17, 2025.                                                                                                                                                                                                         
 Securities Purchase Agreement, by and between Medicus Pharma Ltd. and YA II PN, Ltd., dated September 17, 2025.                                                                                                                                   |
|:--------|:----|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 10.2*   |     | Global Guaranty Agreement made by the subsidiaries of Medicus Pharma Ltd. set forth in Schedule I thereto, dated September 17, 2025.                                                                                                              |
| 104     |     | Cover Page Interactive Data File (formatted as Inline XBRL document).                                                                                                                                                                             |
| *       |     | Certain portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The Company agrees to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission upon its request. |
| 

#